Skip to content
by Legal Desire
22 July 2020

Clifford Chance advises on US$525 million healthcare IT acquisition for Ardian’s portfolio company Dedalus

Advising firms

Deal team

22 lawyers named
LawyerFirmSeniorityPracticeOffice
Kevin Lehpamer Lead Clifford Chance Partner corporate New York
Neil Barlow Clifford Chance Associate Not stated New York
Katerina Papacosma Clifford Chance Associate Not stated New York
Eric Schaffer Clifford Chance Associate Not stated New York
Paolo Sersale Clifford Chance Partner corporate Milan
Filippo Isacco Clifford Chance Counsel Not stated Milan
Elisa Ielpo Clifford Chance Associate Not stated Milan
Mariasole Rinciari Clifford Chance Associate Not stated Milan
Charles Adams Clifford Chance Partner Finance Milan
David Neu Clifford Chance Associate Finance Milan
Francesco De Micheli Clifford Chance Associate Finance Milan
Daryl Fairbairn Clifford Chance Counsel IP/IT New York
Jennifer Saionz Clifford Chance Associate IP/IT New York
Philip Wagman Clifford Chance Partner Tax New York
Sean Smestad Clifford Chance Associate Tax New York
Chinwe Odimba-Chapman Clifford Chance Partner Employment Not stated
Alistair Green Clifford Chance Associate Employment Not stated
Sarah McAleer Clifford Chance Partner Pensions Not stated
Matthew Preston Clifford Chance Associate Pensions Not stated
Andrew Patterson Clifford Chance Partner Incentives London
Luciano Di Via Clifford Chance Partner Antitrust/Regulatory Rome
Antonio Mirabile Clifford Chance Associate Antitrust/Regulatory Rome

Stated terms

Stated value
USD 525m (US$525 million)
What the figure measures
Total transaction value
Client
ArdianInvestor
Counterparties
The Dedalus Group (Buy-side)
DXC Technology (Sell-side)